Literature DB >> 1875956

History of pain concepts and pain therapy.

J J Bonica1.   

Abstract

The development of the concept of pain and its treatment constitutes one of the most interesting and fascinating chapters in the history of medicine. The concept proposed by Aristotle and other ancient Greek philosophers that pain was a passion of the soul remained widely accepted for some 22 centuries, and treatment remained empirical and often ineffective. For a century after the scientific study of pain began, several theories were proposed, and these theories prompted the development of various therapeutic modalities. However, until two decades ago, pain research remained conceptually stagnant; the meager work done was not commensurate with the magnitude and clinical importance of pain. Consequently, pain treatment remained somewhat empirical and ineffective. Whatever knowledge and effective therapeutic modalities were available were not properly applied, primarily because medical students and physicians were not taught the basic principles of pain management. Fortunately, during the past two decades, significant advances have been made in our knowledge of basic mechanisms and a variety of new modalities have been introduced and old ones refined. Although we should be proud of these advances, much more needs to be done if the millions of patients with acute and chronic pain are to be managed effectively. This requires sustaining and expanding research programs; educating and training health professionals; and informing the public.

Entities:  

Mesh:

Year:  1991        PMID: 1875956

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  15 in total

1.  Self-reported pain sensitivity: lack of correlation with pain threshold and tolerance.

Authors:  Robert R Edwards; Roger B Fillingim
Journal:  Eur J Pain       Date:  2006-11-22       Impact factor: 3.931

2.  Abnormal anterior pretectal nucleus activity contributes to central pain syndrome.

Authors:  Peter D Murray; Radi Masri; Asaf Keller
Journal:  J Neurophysiol       Date:  2010-03-31       Impact factor: 2.714

3.  Are intensive data collection methods in pain research feasible in those with physical disability? A study in persons with chronic pain and spinal cord injury.

Authors:  A L Kratz; C Z Kalpakjian; R A Hanks
Journal:  Qual Life Res       Date:  2017-01-17       Impact factor: 4.147

4.  Medicate or Meditate? Greater Pain Acceptance is Related to Lower Pain Medication Use in Persons With Chronic Pain and Spinal Cord Injury.

Authors:  Anna L Kratz; John F Murphy; Claire Z Kalpakjian; Philip Chen
Journal:  Clin J Pain       Date:  2018-04       Impact factor: 3.442

5.  Abnormal activity of primary somatosensory cortex in central pain syndrome.

Authors:  Raimi L Quiton; Radi Masri; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2010-07-21       Impact factor: 2.714

6.  Chronic pain following spinal cord injury.

Authors:  Radi Masri; Asaf Keller
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Zona incerta: a role in central pain.

Authors:  Radi Masri; Raimi L Quiton; Jessica M Lucas; Peter D Murray; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2009-04-29       Impact factor: 2.714

8.  Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions.

Authors:  Gexin Wang; Scott M Thompson
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

9.  The phenomenological-existential comprehension of chronic pain: going beyond the standing healthcare models.

Authors:  Daniela Dantas Lima; Vera Lucia Pereira Alves; Egberto Ribeiro Turato
Journal:  Philos Ethics Humanit Med       Date:  2014-01-10       Impact factor: 2.464

10.  Pain After Spinal Cord Injury Is Associated With Abnormal Presynaptic Inhibition in the Posterior Nucleus of the Thalamus.

Authors:  Anthony Park; Olivia Uddin; Ying Li; Radi Masri; Asaf Keller
Journal:  J Pain       Date:  2018-03-02       Impact factor: 5.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.